# embecta to Report Fiscal Second Quarter Financial Results
Canonical URL: https://biopharmsignal.com/news/EMBC/embecta-to-report-fiscal-second-quarter-financial-results
Ticker: EMBC
Company: Embecta
Source: Embecta
Published: 2026-04-21 21:00 EST
Original Source URL: https://investors.embecta.com
## Summary

PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial

## Article Body
PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial
## Recent Company News
- 2026-06-01 21:00 EST — [embecta to Participate in Investor Events](https://biopharmsignal.com/news/EMBC/embecta-to-participate-in-investor-events) — Source: Embecta
- 2026-05-15 13:00 EST — [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://biopharmsignal.com/news/EMBC/embecta-completes-acquisition-of-owen-mumford-holdings-limited) — Source: Embecta
- 2026-05-08 13:00 EST — [embecta to Participate at the 2026 BofA Securities Global Health Care Conference](https://biopharmsignal.com/news/EMBC/embecta-to-participate-at-the-2026-bofa-securities-global-health-care-conference) — Source: Embecta
- 2026-05-05 10:30 EST — [Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results](https://biopharmsignal.com/news/EMBC/embecta-corp-reports-second-quarter-fiscal-2026-financial-results) — Source: Embecta
- 2026-05-05 10:30 EST — [embecta Announces Quarterly Cash Dividend](https://biopharmsignal.com/news/EMBC/embecta-announces-quarterly-cash-dividend) — Source: Embecta
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)